116 related articles for article (PubMed ID: 30339745)
21. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
[TBL] [Abstract][Full Text] [Related]
22. Claudins and pathogenesis of viral infection.
Tawar RG; Colpitts CC; Lupberger J; El-Saghire H; Zeisel MB; Baumert TF
Semin Cell Dev Biol; 2015 Jun; 42():39-46. PubMed ID: 25960372
[TBL] [Abstract][Full Text] [Related]
23. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
[TBL] [Abstract][Full Text] [Related]
24. Trachelogenin, a novel inhibitor of hepatitis C virus entry through CD81.
Qian XJ; Jin YS; Chen HS; Xu QQ; Ren H; Zhu SY; Tang HL; Wang Y; Zhao P; Qi ZT; Zhu YZ
J Gen Virol; 2016 May; 97(5):1134-1144. PubMed ID: 26879209
[TBL] [Abstract][Full Text] [Related]
25. CD81 and hepatitis C virus (HCV) infection.
Fénéant L; Levy S; Cocquerel L
Viruses; 2014 Feb; 6(2):535-72. PubMed ID: 24509809
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry.
Diao J; Pantua H; Ngu H; Komuves L; Diehl L; Schaefer G; Kapadia SB
J Virol; 2012 Oct; 86(20):10935-49. PubMed ID: 22855500
[TBL] [Abstract][Full Text] [Related]
27. In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface.
Davis C; Harris HJ; Hu K; Drummer HE; McKeating JA; Mullins JG; Balfe P
Cell Microbiol; 2012 Dec; 14(12):1892-903. PubMed ID: 22897233
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus infection and tight junction proteins: The ties that bind.
Mailly L; Baumert TF
Biochim Biophys Acta Biomembr; 2020 Jul; 1862(7):183296. PubMed ID: 32268133
[TBL] [Abstract][Full Text] [Related]
29. Hepatoma polarization limits CD81 and hepatitis C virus dynamics.
Harris HJ; Clerte C; Farquhar MJ; Goodall M; Hu K; Rassam P; Dosset P; Wilson GK; Balfe P; Ijzendoorn SC; Milhiet PE; McKeating JA
Cell Microbiol; 2013 Mar; 15(3):430-45. PubMed ID: 23126643
[TBL] [Abstract][Full Text] [Related]
30. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
[TBL] [Abstract][Full Text] [Related]
31. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
[TBL] [Abstract][Full Text] [Related]
32. Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner.
Fletcher NF; Sutaria R; Jo J; Barnes A; Blahova M; Meredith LW; Cosset FL; Curbishley SM; Adams DH; Bertoletti A; McKeating JA
Hepatology; 2014 Apr; 59(4):1320-30. PubMed ID: 24259385
[TBL] [Abstract][Full Text] [Related]
33. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent.
Molina S; Castet V; Pichard-Garcia L; Wychowski C; Meurs E; Pascussi JM; Sureau C; Fabre JM; Sacunha A; Larrey D; Dubuisson J; Coste J; McKeating J; Maurel P; Fournier-Wirth C
J Virol; 2008 Jan; 82(1):569-74. PubMed ID: 17942559
[TBL] [Abstract][Full Text] [Related]
34. Claudin-6 and Occludin Natural Variants Found in a Patient Highly Exposed but Not Infected with Hepatitis C Virus (HCV) Do Not Confer HCV Resistance In Vitro.
Fénéant L; Ghosn J; Fouquet B; Helle F; Belouzard S; Vausselin T; Séron K; Delfraissy JF; Dubuisson J; Misrahi M; Cocquerel L
PLoS One; 2015; 10(11):e0142539. PubMed ID: 26561856
[TBL] [Abstract][Full Text] [Related]
35. Tandem overexpression of five human factors renders murine hepatocytes susceptible to hepatitis C virus.
Lv L; Kang Q; Yu X; Gao B; Hu T; Ma P; Zhang Y; Yan F; Xiao J; Deng J; Zhou X; Xu J
Acta Virol; 2015 Mar; 59(1):20-6. PubMed ID: 25790047
[TBL] [Abstract][Full Text] [Related]
36. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
Perrault M; Pécheur EI
Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx.
Grigorov B; Reungoat E; Gentil Dit Maurin A; Varbanov M; Blaising J; Michelet M; Manuel R; Parent R; Bartosch B; Zoulim F; Ruggiero F; Pécheur EI
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27930836
[TBL] [Abstract][Full Text] [Related]
38. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry.
Zhu YZ; Luo Y; Cao MM; Liu Y; Liu XQ; Wang W; Wu DG; Guan M; Xu QQ; Ren H; Zhao P; Qi ZT
Virology; 2012 Aug; 429(2):112-23. PubMed ID: 22560863
[TBL] [Abstract][Full Text] [Related]
39. Use of Modified
Beier LS; Rossa J; Woodhouse S; Bergmann S; Kramer HB; Protze J; Eichner M; Piontek A; Vidal-Y-Sy S; Brandner JM; Krause G; Zitzmann N; Piontek J
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561440
[TBL] [Abstract][Full Text] [Related]
40. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.
Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT
J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
